300404 Boji Medical Technology
- 9.46
- -0.03-0.32%
Boji Medical Technology News
Boji Pharmaceutical: Progress Announcement on the Use of Temporarily Idle Raised Funds for Cash Management and Expiry and Redemption
Boji Pharmaceuticals: 300404 Boji Pharmaceuticals Investor Relations Management Information 20241028
Boji Pharmaceutical: Beijing Kangda (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s Cancellation of Some Restricted Shares
Boji Pharmaceutical: Beijing Kangda (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s Cancellation of Some Stock Options
Boji Pharmaceutical: Announcement of Resolutions of the 11th Meeting of the Fifth Board of Supervisors
Boji Pharmaceutical: Announcement of Resolutions of the 11th Meeting of the Fifth Board of Directors
Boji Pharmaceutical: Announcement on the Company Obtaining an Invention Patent Certificate
Broge Pharmaceuticals: Announcement on the progress of external guarantees
Boji Pharmaceutical: Progress Announcement on the Use of Temporarily Idle Raised Funds for Cash Management, Expiration, and Continued Cash Management
Boji Pharmaceutical: Guangfa Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on the company
Boji Pharmaceutical: Announcement on the completion of sales of some special fund-raising accounts
Boji Pharmaceuticals: 300404 Boji Pharmaceuticals Investor Relations Management Information 20240828
Boji Pharmaceutical: Notice on Using Temporarily Idle Raised Funds for Cash Management
Boji Pharmaceutical: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Boji Pharmaceutical: Beijing Kangda (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s Cancellation of Some Stock Options
Boji Pharmaceutical: Opinions of Guangfa Securities Co., Ltd. on the Company\'s Use of Temporarily Idle Own Funds for Cash Management
Boji Pharmaceuticals: Announcement on Proposed Renewal of the Accounting Firm
Boji Pharmaceuticals: Announcement of Board Resolutions
Boji Pharmaceuticals: Announcement of Supervisory Board Resolutions
Boji Pharmaceutical: Beijing Kangda (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s Repurchase, Cancellation, and Cancellation of Some Restricted Shares
Analysis
Price Target
No Data
No Data